top of page
2007 CONGRESS
National Pharmaceutical Congress II
November 28, 2007
Overview:
The National Pharmaceutical Congress of 2007 was divided into three rapid-fire sessions entitled The Operating Climate, The Patient/Physician Climate, and The Innovation/Creativity Climate. These sessions provided the opportunity for leaders in the life sciences industry to present reflections, ideas and innovations.
Agenda
Rapid Fire Session I: The Operating Climate
Welcoming Remarks
Joseph Knott
The Pangaea Group of Companies
Industry Overview
Ronnie Miller
Canada's Research-Based Pharmaceutical Companies (Rx&D)
Greg Glenn
The JBL Group
Graham Jobson
Solvay Pharma Inc.
Andy McClenaghan
P&G Pharmaceuticals Canada
Oxford Debate I
​
Moderator: Dr. Shafiq Qaadri, MPP,
Parliamentary Assistant to the Minister of Health Promotion
​
For the affirmative: Dr. David R. Greenberg, D. Dave HealthCare Solutions
​
For the negative: Marc Lalande,
Council for Continuing Pharmaceutical Education (CCPE)
​
Resolved: This house believes the role of the professional pharmaceutical representatives is outmoded and recommends an industry-wide reduction of drug reps by 20 percent
Nutritional Break, Networking
Rapid Fire Session II: The Patient/Physician Climate
Introduction
Bruce Good
IMS Health Canada
Ron Clark
Nycomed Canada
Vince Lamanna
Novo Nordisk Canada Inc.
Michael Luther
Merck Research Laboratories
Ray Chepesiuk
Pharmaceutical Advertising Advisory Board (PAAB)
Audience Q&A
Rapid Fire Session III: The Innovation/Creativity Climate
Introduction
Mitch Shannon
Chronicle Companies
Mark Beaudet
Paladin Labs Inc.
Patrick Cashman
Lundbeck Canada Inc.
Richard MacKay
Stiefel Canada Inc.
Audience Q&A
Concluding Remarks and Summary
Mitch Shannon
Chronicle Companies
Canadian Healthcare Marketing Hall of Fame Reception
followed by
Canadian Healthcare Marketing Hall of Fame Gala Luncheon
bottom of page